Showing 1 - 10 of 15
Starting from December 2012, insurers in the European Union were prohibited from charging gender-discriminatory prices. We examine the effect of this unisex mandate on risk segmentation in the German health insurance market. While gender used to be a pricing factor in Germany's private health...
Persistent link: https://www.econbiz.de/10012906485
Starting from December 2012, insurers in the European Union were prohibited from charging gender-discriminatory prices. We examine the effect of this unisex mandate on risk segmentation in the German health insurance market. While gender used to be a pricing factor in Germany's private health...
Persistent link: https://www.econbiz.de/10012892016
Starting from December 2012, insurers in the European Union were prohibited from charging gender-discriminatory prices. We examine the effect of this unisex mandate on risk segmentation in the German health insurance market. While gender used to be a pricing factor in Germany's private health...
Persistent link: https://www.econbiz.de/10011961924
Starting from December 2012, insurers in the European Union were prohibited from charging gender-discriminatory prices. We examine the effect of this unisex mandate on risk segmentation in the German health insurance market. While gender used to be a pricing factor in Germany's private health...
Persistent link: https://www.econbiz.de/10011968915
Starting from December 2012, insurers in the European Union were prohibited from charging gender-discriminatory prices. We examine the effect of this unisex mandate on risk segmentation in the German health insurance market. While gender used to be a pricing factor in Germany's private health...
Persistent link: https://www.econbiz.de/10011951076
Persistent link: https://www.econbiz.de/10003755796
Persistent link: https://www.econbiz.de/10013285693
Persistent link: https://www.econbiz.de/10013179153
Persistent link: https://www.econbiz.de/10011916312
In light of increasing health care expenditures, patient cost-sharing schemes have emerged as one of the main policy tools to reduce medical spending. We show that the effect of patient cost-sharing schemes on health care expenditures is not only determined by the economic incentives they...
Persistent link: https://www.econbiz.de/10011855694